Construction of recombinant baculovirus vaccines for Newcastle disease virus and an assessment of their immunogenicity
Authors:
- 1 August 2016
- journal article
- Published by Elsevier in Journal of Biotechnology
- Vol. 231, 201-211
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31470537)
- National Natural Science Foundation of China (31270534)
- National Natural Science Foundation of China (31270143)
- National Science Foundation for Distinguished Young Scholars of China (31570492)
- Innovation Team in Science and Technology of Heilongjiang Province (2012td009)
This publication has 22 references indexed in Scilit:
- Newcastle disease in the European Union 2000 to 2009Avian Pathology, 2011
- Evaluation of the Newcastle Disease Virus F and HN Proteins in Protective Immunity by Using a Recombinant Avian Paramyxovirus Type 3 Vector in ChickensJournal of Virology, 2011
- Baculoviral Vectors for Gene Delivery: A ReviewCurrent Gene Therapy, 2008
- Sequence variation in the Newcastle disease virus genomeVirus Research, 2006
- Baculovirus Vectors for Gene Therapy2006
- Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivoGene Therapy, 2005
- The structural biology of type I viral membrane fusionNature Reviews Molecular Cell Biology, 2003
- Current status of DNA vaccines in veterinary medicineAdvanced Drug Delivery Reviews, 2000
- Effect of Bacillus subtilis spore administration on activation of macrophages and natural killer cells in miceVeterinary Microbiology, 1998
- PLAQUE ASSAYS1992